Related references
Note: Only part of the references are listed.Treatment options in type-2 low asthma
Timothy S. C. Hinks et al.
EUROPEAN RESPIRATORY JOURNAL (2021)
Suboptimal treatment response to anti-IL-5 monoclonal antibodies in severe eosinophilic asthmatics with airway autoimmune phenomena
Manali Mukherjee et al.
EUROPEAN RESPIRATORY JOURNAL (2020)
Role of Platelet-Derived Growth Factor (PDGF) in Asthma as an Immunoregulatory Factor Mediating Airway Remodeling and Possible Pharmacological Target
Grzegorz Kardas et al.
FRONTIERS IN PHARMACOLOGY (2020)
Mast cells in asthma: Here I am, stuck in the middle with you
Raymond B. Penn
EUROPEAN RESPIRATORY JOURNAL (2020)
ERS/EAACI statement on severe exacerbations in asthma in adults: facts, priorities and key research questions
Arnaud Bourdin et al.
EUROPEAN RESPIRATORY JOURNAL (2019)
Severe Eosinophilic Asthma
Agamemnon Bakakos et al.
JOURNAL OF CLINICAL MEDICINE (2019)
An Allosteric Anti-tryptase Antibody for the Treatment of Mast Cell-Mediated Severe Asthma
Henry R. Maun et al.
CELL (2019)
KIT Inhibition by Imatinib in Patients with Severe Refractory Asthma
Katherine N. Cahill et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Anti-IL5 therapies for asthma
Hugo A. Farne et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2017)
Mast cells in asthma - state of the art
P. Bradding et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2016)
International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma
Kian Fan Chung et al.
EUROPEAN RESPIRATORY JOURNAL (2014)
The Tyrosine Kinase Inhibitor Masitinib Blunts Airway Inflammation and Improves Associated Lung Mechanics in a Feline Model of Chronic Allergic Asthma
Tekla M. Lee-Fowler et al.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2012)
Mast Cell Phenotype, Location, and Activation in Severe Asthma Data from the Severe Asthma Research Program
Silvana Balzar et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
The Role of Mast Cells in the Structural Alterations of the Airways as a Potential Mechanism in the Pathogenesis of Severe Asthma
R. J.F. Carter et al.
CURRENT PHARMACEUTICAL DESIGN (2011)
Effect of Imatinib on Airway Smooth Muscle Thickening in a Murine Model of Chronic Asthma
Chin Kook Rhee et al.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2011)
Masitinib, a c-kit/PDGF receptor tyrosine kinase inhibitor, improves disease control in severe corticosteroid-dependent asthmatics
M. Humbert et al.
ALLERGY (2009)
An Official American Thoracic Society/European Respiratory Society Statement: Asthma Control and Exacerbations Standardising Endpoints for Clinical Asthma Trials and Clinical Practice
Helen K. Reddel et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2009)
Masitinib (AB1010), a Potent and Selective Tyrosine Kinase Inhibitor Targeting KIT
Patrice Dubreuil et al.
PLOS ONE (2009)
Measurement properties and interpretation of three shortened versions of the asthma control questionnaire
EF Juniper et al.
RESPIRATORY MEDICINE (2005)
Mast-cell infiltration of airway smooth muscle in asthma
CE Brightling et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Share Paper
